3,5-dibromo-1-[(2E)-3-phenylprop-2-en-1-yl]-1H-1,2,4-triazole, 95.0%, 1g

Vesatolimod, 99.90%, 10mg

O-tert-Butyl-L-tyrosine allyl ester hydrochloride, 98.0%, 5g

4-Chloro-5-phenyl-thieno[2,3-d]pyrimidine, 95.0%, 1g

N-(3-Fluorophenyl)piperidin-4-amine hydrochloride, 95.0%, 1g

Methyl 4-[(1s)-1-hydroxyethyl]benzoate, 95%, 50mg

4-(Toluene-4-sulfonyloxy)-piperidine-1-carboxylic acid tert-butyl ester, 96.0%, 25g

3-Cyano-3-methylpyrrolidine hydrochloride, 97.0%, 10g

DL-Methionine Sulfone>99.0%(T)5g

(2S,4R)-1-(tert-butoxycarbonyl)-4-(2-cyanobenzyl)pyrrolidine-2-carboxylic acid, 95+%, 250mg

Columna HPLC NUCLEODUR® NH2-RP 3 µm, 250 mm, 1 Pieza(s)

1-Allyl-3-(pyridin-2-yl)thiourea, 95%, 10mg

6-(Trifluoromethyl)imidazo[2,1-b]thiazole-5-carbaldehyde, 95.0%, 1g